Bahbah Ali, Sengupta Jay, Kapphahn-Bergs Melanie, Witt Dawn, Zishiri Edwin, Sharkey Scott, Strepkos Dimitrios, Alexandrou Michaella, Abdelhadi Raed, Hauser Robert
The Joseph F. Novogratz Family Heart Rhythm Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
J Cardiovasc Electrophysiol. 2024 Dec;35(12):2397-2401. doi: 10.1111/jce.16458. Epub 2024 Oct 13.
The Medtronic Micra VR and Abbott AVEIR VR are the leadless pacemakers (LPM) currently available in the United States (US). Micra VR employs fixation tines and the AVEIR VR uses an active fixation helix. Micra VR requires fixation before electrical measurements are obtained, while R-waves may be mapped by AVEIR VR without fixation. Little comparative data is available for these LPMs. Accordingly, we compared the incidences of procedure-related major adverse clinical events (MACE) and device problems in the US for Micra VR and AVEIR VR during 2022-2024.
We searched the FDA's Manufacturer and User Facility Device Experience (MAUDE) database for US reports of MACE and device problems that were filed from April 2022 to December 2023 for AVEIR VR, and from June 2022 to April 2024 for Micra VR. Totals for US-registered LPM implants were obtained from the manufacturers' product performance reports.
During the study period, 5990 AVEIR VR and 10 940 Micra VR implants were registered in the US. We found 305 MAUDE reports for AVEIR VR (5.1%), versus 541 MAUDE reports for Micra VR (4.9%) (p = .702). The incidence of MACE was 0.72% (43/5990) for AVEIR VR versus 0.59% (65/10 940) for Micra VR, (p = .387). The incidences of procedure-related death, cardiac perforation. cardiac arrest, emergency pericardial drainage or reparative surgery were similar for both LPMs (p > .05). Micra VR had more unacceptable thresholds requiring LPM replacement compared to AVEIR VR (95;0.9% vs. 24;0.4%; p = .001). AVEIR VR had a statistically higher incidence of device dislodgement during (32) and after (21) implant compared to Micra VR (53 (0.9%) vs. 46 (0.4%), p < .001).
Micra VR and AVEIR VR have similar procedural safety profiles, including the incidences of death and perforation. However, device problems differed significantly, possibly related to their design differences. Compared to Micra VR, AVEIR VR appears to have an advantageous threshold measurement capability but is more prone to device dislodgement.
美敦力Micra VR和雅培AVEIR VR是目前在美国可用的无导线起搏器(LPM)。Micra VR采用固定齿,而AVEIR VR使用主动固定螺旋。Micra VR在获得电测量之前需要固定,而AVEIR VR在未固定的情况下可以映射R波。关于这些LPM的比较数据很少。因此,我们比较了2022年至2024年期间美国Micra VR和AVEIR VR与手术相关的主要不良临床事件(MACE)和设备问题的发生率。
我们在美国食品药品监督管理局(FDA)的制造商和用户设施设备经验(MAUDE)数据库中搜索了2022年4月至2023年12月提交的关于AVEIR VR的MACE和设备问题的美国报告,以及2022年6月至2024年4月提交的关于Micra VR的报告。美国注册的LPM植入总数来自制造商的产品性能报告。
在研究期间,美国注册了5990例AVEIR VR植入和10940例Micra VR植入。我们发现AVEIR VR有305份MAUDE报告(5.1%),而Micra VR有541份MAUDE报告(4.9%)(p = 0.702)。AVEIR VR的MACE发生率为0.72%(43/5990),而Micra VR为0.59%(65/10940),(p = 0.387)。两种LPM与手术相关的死亡、心脏穿孔、心脏骤停、紧急心包引流或修复手术的发生率相似(p > 0.05)。与AVEIR VR相比,Micra VR有更多不可接受的阈值需要更换LPM(95例;0.9%对24例;0.4%;p = 0.001)。与Micra VR相比,AVEIR VR在植入期间(32例)和植入后(21例)设备移位的发生率在统计学上更高(53例(0.9%)对46例(0.4%),p < 0.001)。
Micra VR和AVEIR VR具有相似的手术安全性,包括死亡和穿孔的发生率。然而,设备问题存在显著差异,可能与其设计差异有关。与Micra VR相比,AVEIR VR似乎具有有利的阈值测量能力,但更容易发生设备移位。